Hatteras Venture Partners is a Durham, North Carolina–based venture capital firm founded in 2000 that specializes in early-stage and seed investments in companies advancing transformative healthcare and life sciences innovations, with core focus areas including biotechnology, medical devices, diagnostics, healthtech and related human medicine opportunities. It seeks to build companies emerging from cutting-edge science, often collaborating with founders, academic research institutions and co-investors to support development from proof of concept through commercial growth. The firm manages multiple funds and has deployed capital into numerous U.S. healthcare companies, particularly in major innovation hubs and the Southeastern United States, while maintaining a national investment footprint. Hatteras combines financial capital with strategic guidance, sector expertise and industry networks to help portfolio companies navigate clinical, regulatory and commercialization pathways. Its portfolio includes companies advancing novel therapies, medical technologies and digital health solutions across diverse healthcare segments.